Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Revenue (2023 - 2025)

Upstream Bio (UPB) has 3 years of Revenue data on record, last reported at $683000.0 in Q3 2025.

  • For Q3 2025, Revenue rose 12.52% year-over-year to $683000.0; the TTM value through Sep 2025 reached $2.8 million, up 26.82%, while the annual FY2024 figure was $2.4 million, 0.42% changed from the prior year.
  • Revenue reached $683000.0 in Q3 2025 per UPB's latest filing, down from $937000.0 in the prior quarter.
  • Across five years, Revenue topped out at $937000.0 in Q2 2025 and bottomed at $450000.0 in Q4 2023.
  • Average Revenue over 3 years is $625750.0, with a median of $610000.0 recorded in 2024.
  • The widest YoY moves for Revenue: up 83.73% in 2025, down 11.56% in 2025.
  • A 3-year view of Revenue shows it stood at $450000.0 in 2023, then soared by 36.22% to $613000.0 in 2024, then grew by 11.42% to $683000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $683000.0 in Q3 2025, $937000.0 in Q2 2025, and $566000.0 in Q1 2025.